NCT00576849View on ClinicalTrials.gov

A Total Balanced Volume Replacement Regimen in Elderly Cardiac Surgery Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
ElderlyCardiac Surgery
Interventions
DRUG

Balanced HES 130/0.42

Volume is administered perioperatively and during the first 48 hrs after surgery when mean arterial pressure (MAP) was \<60mmHg and pulmonary capillary wedge pressure (PCWP) or central venous pressure (CVP) is \<10 mmHg

DRUG

Balanced HES 130/0.42

Volume will be administered perioperatively and during the first 48 hrs after surgery when mean arterial pressure (MAP) is \<60mmHg and pulmonary capillary wedge pressure (PCWP) or central venous pressure (CVP) is \<10 mmHg

DRUG

6% HES 130/0.4 prepared in saline solution

Volume will be administered perioperatively and during the first 48 hrs after surgery when mean arterial pressure (MAP) is \<60mmHg and pulmonary capillary wedge pressure (PCWP) or central venous pressure (CVP) is \<10 mmHg

Trial Locations (1)

67063

Klinikum Ludwigshafen, Ludwigshafen

All Listed Sponsors
lead

Klinikum Ludwigshafen

OTHER

NCT00576849 - A Total Balanced Volume Replacement Regimen in Elderly Cardiac Surgery Patients | Biotech Hunter | Biotech Hunter